Advertisement
Canada markets closed

  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     

  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     

  • DOW

    39,056.39
    +172.13 (+0.44%)
     

  • CAD/USD

    0.7282
    -0.0006 (-0.08%)
     

  • CRUDE OIL

    79.29
    +0.30 (+0.38%)
     

  • Bitcoin CAD

    84,113.97
    -1,708.68 (-1.99%)
     

  • CMC Crypto 200

    1,303.76
    +9.09 (+0.70%)
     

  • GOLD FUTURES

    2,314.90
    -7.40 (-0.32%)
     

  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     

  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     

  • NASDAQ futures

    18,157.75
    -28.75 (-0.16%)
     

  • VOLATILITY

    13.00
    -0.23 (-1.74%)
     

  • FTSE

    8,354.05
    +40.38 (+0.49%)
     

  • NIKKEI 225

    38,240.07
    +37.70 (+0.10%)
     

  • CAD/EUR

    0.6775
    -0.0001 (-0.01%)
     

Today's Research Reports on Cipher Pharmaceuticals Inc., Canopy Growth Corporation, Titan Medical Inc. and Nuvo Pharmaceuticals Inc.

ACCESSWIRE

NEW YORK, NY / ACCESSWIRE / August 16, 2017 / Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://rdinvesting.com and get exclusive access to our numerous research reports and market updates.

RDI has Initiated Coverage Today on:

Cipher Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=CPH-TO

Canopy Growth Corporation
https://ub.rdinvesting.com/news/?ticker=WEED-TO

Titan Medical Inc.
https://ub.rdinvesting.com/news/?ticker=TMD-TO

Nuvo Pharmaceuticals Inc.
https://ub.rdinvesting.com/news/?ticker=NRI-TO

ADVERTISEMENT

Cipher Pharmaceuticals Inc.'s stock moved 1.34% higher Tuesday, to close the day at $5.31. The stock recorded a trading volume of 11,150 shares, which was below its three months average volume of 18,435 shares. In the last year Cipher Pharmaceuticals Inc.'s shares have traded in a range of 3.50 - 6.00. The share price has gained 51.71% from its 52 week low. The company's shares are currently trading above their 200-day moving average. Moreover, the stock's 50-day moving average of $5.39 is greater than its 200-day moving average of $4.97. Shares of Cipher Pharmaceuticals have gained approximately 8.37 percent year-to-date.

Access RDI's Cipher Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=CPH-TO

On Tuesday, shares in Canopy Growth Corporation recorded a trading volume of 679,279 shares, which was below the three months average volume of 1,081,570 shares. The stock ended the day 0.56% lower at 8.91. The share price has gained 144.11% from its 52 week low with a 52 week trading range of 3.65 - 17.86.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $8.46 is below its 200-day moving average of $9.43. Shares of Canopy Growth have fallen approximately 2.52 percent year-to-date.

Access RDI's Canopy Growth Corporation Research Report at:
https://ub.rdinvesting.com/news/?ticker=WEED-TO

Titan Medical Inc.'s stock moved 3.57% lower Tuesday, to close the day at $0.14. The stock recorded a trading volume of 564,693 shares, which was below its three months average volume of 751,359 shares. In the last year Titan Medical Inc.'s shares have traded in a range of 0.13 - 0.75. The stock is currently trading 82.00% below its 52 week high. The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $0.14 is below its 200-day moving average of $0.32. Shares of Titan Medical have fallen approximately 57.81 percent year-to-date.

Access RDI's Titan Medical Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=TMD-TO

On Tuesday, shares in Nuvo Pharmaceuticals Inc. recorded a trading volume of 7,095 shares, which was below the three months average volume of 16,610 shares. The stock ended the day flat at 4.00. The stock is currently trading 52.10% below its 52 week high with a 52 week trading range of 3.76 - 8.35.The company's shares are currently trading below their 200-day moving average. Moreover, the stock's 50-day moving average of $4.06 is below its 200-day moving average of $4.88. Shares of Nuvo Pharmaceuticals Inc. are trading at a Price to Earnings ratio of 9.30. Shares of Nuvo Pharmaceuticals have fallen approximately 29.2 percent year-to-date.

Access RDI's Nuvo Pharmaceuticals Inc. Research Report at:
https://ub.rdinvesting.com/news/?ticker=NRI-TO

Our Actionable Research on Cipher Pharmaceuticals Inc. (TSX:CPH.TO), Canopy Growth Corporation (TSX:WEED.TO), Titan Medical Inc. (TSX:TMD.TO) and Nuvo Pharmaceuticals Inc. (TSX:NRI.TO) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@rdinvesting.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com